SCHEMBL2228558

SCHEMBL2228558

CSc1ccc(S(N)(=O)=O)cc1CNc1cc(Nc2ccc3c(c2)OCO3)ncn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNA2 P20248 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
EGFR P00533 2/20 0.41
ERBB3 P21860 2/20 0.41
TNNI3K Q59H18 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TGFBR1 P36897 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225385 0.95 CDK1 (0.43) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2227241 0.84 CDK1 (0.46) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2227638 0.84 TNNI3K (0.57) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2226860 0.83 TNNI3K (0.45) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2226143 0.81 CCNA2 (0.47) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2226929 0.81 ALDH1A1 (0.48) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2226099 0.81 IRAK4 (0.44) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2224279 0.80 EGFR (0.53) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2226407 0.80 TNNI3K (0.42) CDK2CDK1CCNB1CCNA2CCNE1
SCHEMBL2224234 0.80 TNNI3K (0.43) CDK2CDK1CCNB1CCNA2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed